EGFR-TKI Alone or with Concomitant Radiotherapy for Brain Metastases in Lung Adenocarcinoma Patients with EGFR Gene Mutations

被引：0
|
作者：
Chen, Yongshun [1 ]
Yang, Jing [2 ]
Li, Xue [1 ]
Hao, Daxuan [1 ]
Wu, Xiaoyuan [1 ]
Yang, Yuanyuan [1 ]
Hu, Xiaona [1 ]
He, Chunyu [1 ]
Wang, Wen [1 ]
Liu, Jinsong [1 ]
Wang, Jianhua [1 ]
机构：
[1] Zhengzhou Univ, Dept Radiat Oncol, Canc Hosp, Henan Canc Hosp, Zhengzhou 450052, Peoples R China
[2] Angang Gen Hosp, Anyang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Brain metastasis; EGFR mutation; lung adenocarcinoma; Radiotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI05.10
引用
收藏
页码：S278 / S278
页数：1
相关论文
共 50 条
  • [41] Peritoneal relapse from lung adenocarcinoma after a response to EGFR-TKI
    Satoh, Hiroaki
    Kagohashi, Katsunori
    Kurishima, Koichi
    [J]. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX, 2013, 61 (04): : 346 - 347
  • [42] Brain Radiotherapy with EGFR-TKI Plays an Important Role in 181 EGFR Mutant Non-Small Cell Lung Cancer Patients with Brain Metastasis
    Wang, Wenxian
    Jin, Ying
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1235 - S1235
  • [43] Small cell transformation of lung adenocarcinoma in acquired resistance to EGFR-TKI
    So, Kwang Sup
    Choi, Yun Jung
    Kim, Sun Ye
    Choi, Chang-Min
    Lee, Jae Cheol
    Kim, Woo Sung
    Rho, Jin Kyung
    [J]. CANCER RESEARCH, 2013, 73 (08)
  • [44] Overexpression of RhoV Promotes the Progression and EGFR-TKI Resistance of Lung Adenocarcinoma
    Chen, Hongjin
    Xia, Ruixue
    Jiang, Long
    Zhou, Yong
    Xu, Haojun
    Peng, Weiwei
    Yao, Chengyun
    Zhou, Guoren
    Zhang, Yijie
    Xia, Hongping
    Wang, Yongsheng
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [45] DISCOVERY THE NOVEL COMPOUND FOR OVERCOMING EGFR-TKI RESISTANCE IN LUNG ADENOCARCINOMA
    Huang, Kuo-Yen
    Lin, Chung-Chih
    Yang, Shuenn-Chen
    Yang, Pan-Chyr
    [J]. RESPIROLOGY, 2018, 23 : 176 - 176
  • [46] Primary Tumor Radiotherapy During EGFR-TKI Disease Control Improves Survival of Treatment Naive Advanced EGFR-Mutant Lung Adenocarcinoma Patients
    Hsu, Kuo-Hsuan
    Huang, Jing-Wen
    Tseng, Jeng-Sen
    Chen, Kuan-Wen
    Weng, Yih-Chyang
    Yu, Sung-Liang
    Yang, Tsung-Ying
    Huang, Yen-Hsiang
    Chen, Jeremy Jw
    Chen, Kun-Chieh
    Chang, Gee-Chen
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 2139 - 2148
  • [47] Preventing and Treating Brain Metastases with Three First-Line EGFR-TKI in Patients with EGFR Mutation Advanced NSCLC
    Lin, C.
    Su, W.
    Wu, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S484 - S484
  • [48] Comparison of the effect of two EGFR-TKI in patients with EGFR-mutant lung adenocarcinoma using in silico clinical trials
    Darre, Hippolyte
    Martin, Bastien
    Hammami, Firas
    Nativel, Arnaud
    Lefaudeux, Diane
    Toueg, Raphael
    Duruisseaux, Michael
    Palgen, Jean-Louis
    Masson, Perrine
    L'Hostis, Adele
    Ceres, Nicoletta
    Monteiro, Claudio
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [49] EGFR-TKI Therapy Prolongs Survival In Non-small Cell Lung Cancer Patients With Brain Metastases or Bone Metastases
    Hui, L.
    Xiaomei, G.
    Wei, J.
    Chunxue, B.
    Zhaochong, Z.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S621 - S621
  • [50] The Contribution of Compound EGFR Mutations and Other Co-mutations to Efficacy of EGFR TKI in Lung Adenocarcinoma
    Kwak, S. H.
    Lee, E. H.
    Gwon, H. R.
    Yong, S. H.
    Kim, C. Y.
    Lee, S. H.
    Chang, Y. S.
    Kim, E. Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S662 - S662
12345